Arena Pharmaceuticals
$73.579876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$73.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.06 (+2.88%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell ARNA and other stocks, options, and ETFs commission-free!
About ARNA
Arena Pharmaceuticals, Inc. Common Stock, also called Arena Pharmaceuticals, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA. The listed name for ARNA is Arena Pharmaceuticals, Inc. Common Stock.
CEO
Amit Dilip Munshi
Employees
363
Headquarters
San Diego, California
Founded
1997
Market Cap
4.55B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
666.97K
High Today
$73.82
Low Today
$69.21
Open Price
$71.91
Volume
617.80K
52 Week High
$90.19
52 Week Low
$32.95
ARNA News
Analyst Ratings
100%
of 12 ratings
Buy
100%
Hold
0%
Sell
0%
ARNA Earnings
-$2.28
-$1.88
-$1.48
-$1.08
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$1.85 per share
Actual
-$2.10 per share